Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 3497K) PPT slides of all figures Supplemental Material Index Correction (v172,p953) Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Shin, J.-Y. Articles by Li, X.-J. Search for Related Content PubMed PubMed Citation Articles by Shin, J.-Y. Articles by Li, X.-J. Social Bookmarking                            What's this?

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322

Correspondence to Xiao-Jiang Li: xiaoli{at}genetics.emory.edu

Huntington disease (HD) is characterized by the preferential loss of striatal medium-sized spiny neurons (MSNs) in the brain. Because MSNs receive abundant glutamatergic input, their vulnerability to excitotoxicity may be largely influenced by the capacity of glial cells to remove extracellular glutamate. However, little is known about the role of glia in HD neuropathology. Here, we report that mutant huntingtin accumulates in glial nuclei in HD brains and decreases the expression of glutamate transporters. As a result, mutant huntingtin (htt) reduces glutamate uptake in cultured astrocytes and HD mouse brains. In a neuron–glia coculture system, wild-type glial cells protected neurons against mutant htt-mediated neurotoxicity, whereas glial cells expressing mutant htt increased neuronal vulnerability. Mutant htt in cultured astrocytes decreased their protection of neurons against glutamate excitotoxicity. These findings suggest that decreased glutamate uptake caused by glial mutant htt may critically contribute to neuronal excitotoxicity in HD.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Palazuelos, J., Aguado, T., Pazos, M. R., Julien, B., Carrasco, C., Resel, E., Sagredo, O., Benito, C., Romero, J., Azcoitia, I., Fernandez-Ruiz, J., Guzman, M., Galve-Roperh, I. (2009). Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 132: 3152-3164 [Abstract] [Full Text]  
• Harper, S. Q. (2009). Progress and Challenges in RNA Interference Therapy for Huntington Disease. Arch Neurol 66: 933-938 [Abstract] [Full Text]  
• Cui, M., Aras, R., Christian, W. V., Rappold, P. M., Hatwar, M., Panza, J., Jackson-Lewis, V., Javitch, J. A., Ballatori, N., Przedborski, S., Tieu, K. (2009). The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc. Natl. Acad. Sci. USA 106: 8043-8048 [Abstract] [Full Text]  
• Wang, L., Lin, F., Wu, J., Qin, Z. (2009). High efficiency adenovirus-mediated expression of truncated N-terminal huntingtin fragment (htt552) in primary rat astrocytes. Acta Biochim Biophys Sin 41: 325-334 [Abstract] [Full Text]  
• Guo, S., Lo, E. H. (2009). Dysfunctional Cell-Cell Signaling in the Neurovascular Unit as a Paradigm for Central Nervous System Disease. Stroke 40: S4-S7 [Abstract] [Full Text]  
• Oliveira, J. M. A., Goncalves, J. (2009). In Situ Mitochondrial Ca2+ Buffering Differences of Intact Neurons and Astrocytes from Cortex and Striatum. J. Biol. Chem. 284: 5010-5020 [Abstract] [Full Text]  
• Tydlacka, S., Wang, C.-E., Wang, X., Li, S., Li, X.-J. (2008). Differential Activities of the Ubiquitin-Proteasome System in Neurons versus Glia May Account for the Preferential Accumulation of Misfolded Proteins in Neurons. J. Neurosci. 28: 13285-13295 [Abstract] [Full Text]  
• Wang, C.-E., Zhou, H., McGuire, J. R., Cerullo, V., Lee, B., Li, S.-H., Li, X.-J. (2008). Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. JCB 181: 803-816 [Abstract] [Full Text]  
• Wang, C.-E., Tydlacka, S., Orr, A. L., Yang, S.-H., Graham, R. K., Hayden, M. R., Li, S., Chan, A. W.S., Li, X.-J. (2008). Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease. Hum Mol Genet 17: 2738-2751 [Abstract] [Full Text]  
• Bjorkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R. V., Benn, C. L., Soulet, D., Magnusson, A., Woodman, B., Landles, C., Pouladi, M. A., Hayden, M. R., Khalili-Shirazi, A., Lowdell, M. W., Brundin, P., Bates, G. P., Leavitt, B. R., Moller, T., Tabrizi, S. J. (2008). A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. JEM 205: 1869-1877 [Abstract] [Full Text]  
• Chou, S.-Y., Weng, J.-Y., Lai, H.-L., Liao, F., Sun, S. H., Tu, P.-H., Dickson, D. W., Chern, Y. (2008). Expanded-Polyglutamine Huntingtin Protein Suppresses the Secretion and Production of a Chemokine (CCL5/RANTES) by Astrocytes. J. Neurosci. 28: 3277-3290 [Abstract] [Full Text]  
• Wang, J., Wang, C.-E., Orr, A., Tydlacka, S., Li, S.-H., Li, X.-J. (2008). Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. JCB 180: 1177-1189 [Abstract] [Full Text]  
• Giorgini, F., Moller, T., Kwan, W., Zwilling, D., Wacker, J. L., Hong, S., Tsai, L.-C. L., Cheah, C. S., Schwarcz, R., Guidetti, P., Muchowski, P. J. (2008). Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment. J. Biol. Chem. 283: 7390-7400 [Abstract] [Full Text]  
• Lievens, J.-C., Iche, M., Laval, M., Faivre-Sarrailh, C., Birman, S. (2008). AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease. Hum Mol Genet 17: 882-894 [Abstract] [Full Text]  
• Orr, A. L., Li, S., Wang, C.-E., Li, H., Wang, J., Rong, J., Xu, X., Mastroberardino, P. G., Greenamyre, J. T., Li, X.-J. (2008). N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking. J. Neurosci. 28: 2783-2792 [Abstract] [Full Text]  
• Claassen, D. A., Lahue, R. S. (2007). Expansions of CAG{middle dot}CTG repeats in immortalized human astrocytes. Hum Mol Genet 16: 3088-3096 [Abstract] [Full Text]  
• Powers, W. J., Videen, T. O., Markham, J., McGee-Minnich, L., Antenor-Dorsey, J. V., Hershey, T., Perlmutter, J. S. (2007). Selective defect of in vivo glycolysis in early Huntington's disease striatum. Proc. Natl. Acad. Sci. USA 104: 2945-2949 [Abstract] [Full Text]  
• Rockabrand, E., Slepko, N., Pantalone, A., Nukala, V. N., Kazantsev, A., Marsh, J. L., Sullivan, P. G., Steffan, J. S., Sensi, S. L., Thompson, L. M. (2007). The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16: 61-77 [Abstract] [Full Text]  
• Farrell, B. T., Lahue, R. S. (2006). CAG{middle dot}CTG repeat instability in cultured human astrocytes. Nucleic Acids Res 34: 4495-4505 [Abstract] [Full Text]  
• Rong, J., McGuire, J. R., Fang, Z.-H., Sheng, G., Shin, J.-Y., Li, S.-H., Li, X.-J. (2006). Regulation of intracellular trafficking of huntingtin-associated protein-1 is critical for TrkA protein levels and neurite outgrowth.. J. Neurosci. 26: 6019-6030 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents